Category:Oncology
From Food & Medicine Encyclopedia
Wikimedia Commons has media related to
.
Oncology is the field of medicine that deals with the diagnosis and treatment of cancer.
| Overview of tumors, cancer and oncology | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Subcategories
This category has the following 4 subcategories, out of 4 total.
Pages in category "Oncology"
The following 200 pages are in this category, out of 969 total.
(previous page) (next page)*
A
- Abelson murine leukemia virus
- Ablation
- Abscopal effect
- Aceglatone
- Acinar adenocarcinoma
- Active surveillance
- Activin receptor
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Acute promyelocytic leukemia
- ADAMTS8
- Adenocarcinoma
- Adenocarcinoma in situ of the lung
- Adenocarcinoma of the lung
- Adenoma
- Adenomatous polyposis coli
- Adenovirus E1B protein
- Adstiladrin
- AFP-07
- AFP-L3
- Aggressive digital papillary adenocarcinoma
- Akt/PKB signaling pathway
- AKT1
- AKT2
- AKT3
- ALK positive lung cancer
- Alliance for Clinical Trials in Oncology
- Alpelisib
- Alveolar rhabdomyosarcoma
- Amelanotic melanoma
- American Joint Committee on Cancer
- American Society of Clinical Oncology
- American Society of Pediatric Hematology/Oncology
- Anal dysplasia
- Anal Pap smear
- Anaplasia
- Anaplastic lymphoma kinase
- Anatumomab mafenatox
- Androgen suppression
- Androgen synthesis inhibitor
- Angiogenin
- Angioimmunoblastic T-cell lymphoma
- Angiomatoid fibrous histiocytoma
- Angiozyme
- Angus Dalgleish
- Ann Arbor staging
- Annals of Oncology
- Anticarcinogen
- Antiestrogen
- Antiestrogen withdrawal response
- Antimetabolite
- Antineoplastic and immunomodulating drugs
- Template:Antineoplastic-agents-stub
- Apolizumab
- Apudoma
- Aromatase inhibitor
- Artemin
- Asbestos-related diseases
- Asparaginase erwinia chrysanthemi
- Astrocytoma
- Asunercept
- ATC code L
- ATF3
- ATF4
- Atypia
- AUTEN-67
- Autogene cevumeran
- Automated tissue image analysis
- Avapritinib
- Avulsion fracture
- AZD-3161
B
- B symptoms
- B-cell lymphoma
- B-cell maturation antigen
- Bartholin gland carcinoma
- Basal cell
- Basigin
- Bazex syndrome
- BC200 lncRNA
- Bcl-2
- Bcl-2-associated death promoter
- Bcl-xL
- BCL6
- BCR (gene)
- Bcr-Abl tyrosine-kinase inhibitor
- BeiGene
- Belantamab mafodotin
- Belvarafenib
- Bempegaldesleukin
- Bence
- Benign tumor
- Biochemical recurrence
- Biphenotypic sinonasal sarcoma
- Black salve
- Blast phase
- Blastic phase chronic myelogenous leukemia
- Bombesin
- Bone Cancer Research Trust
- Bone marrow biopsy
- Bone marrow suppression
- Bone metastasis
- Bone-seeking radioisotope
- Borderline tumor
- BRAF
- Brain metastasis
- Brain stem tumor
- BRCA mutation
- BRCA2
- Breast cancer
- Breast Cancer Care
- Breast cancer chemotherapy
- Breast cancer classification
- Breast disease
- Breast prostheses
- Breslow's depth
- Bromodeoxyuridine
- Brontictuzumab
- Bruton's tyrosine kinase
- BTLA
- Buserelin
C
- CA 15-3
- CA 242 (tumor marker)
- CA 27-29
- CA19-9
- Cachexia
- Cancer biology
- Cancer biomarker
- Cancer Care
- Cancer center
- Cancer Center
- Cancer drugs
- Cancer immunology
- Cancer Immunology, Immunotherapy
- Cancer immunotherapy
- Cancer in adolescents and young adults
- Cancer Institute
- Cancer Institute (WIA)
- Cancer Investigation
- Cancer Letters
- Cancer Likelihood in Plasma
- Cancer of unknown primary origin
- Cancer pain
- Cancer pharmacogenomics
- Cancer prevention
- Cancer registry
- Cancer screening
- Cancer selection
- Cancer staging
- Cancer stem cell
- Cancer survival rates
- Cancer terms
- Cancer Treatment
- Cancer-associated fibroblast
- Canine cancer detection
- Caphosol
- Capmatinib
- Carboxycyclophosphamide
- Carcinocythemia
- Carcinoembryonic antigen
- Carcinogen
- Carcinogenesis
- Carcinogenic bacteria
- Carcinoid
- Carcinoma ex pleomorphic adenoma
- Carcinoma in situ
- Carcinosis
- Cardio-oncology
- Cardiotoxicity
- Carney triad
- Cartilage tumor
- Causes of cancer
- CCL12
- CCL17
- CCL24
- CD109
- CD135
- CD137
- CD153
- CD20
- CD23
- CD33
- CD34
- CD37
- CD5 (protein)
- CD52
- CD79B
- CD81
- CD82 (gene)
- CD99
- CDH11
- CDK inhibitor
